Ben Venue Laboratories
(Acquired By Boehringer Ingelheim)
300 Northfield Ridge
About Ben Venue LaboratoriesBen Venue Laboratories, Inc. was founded in 1938 and is a leading contract manufacturer of highly complex, sterile injectable drug products for the global pharmaceutical industry. Ben Venue is located in Bedford, Ohio and employs more than 1,300 people. For more information and current career opportunities, visit www.benvenue.com. Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the BoehringerIngelheim group of companies. http://us.boehringer-ingelheim.com.
The commitment, competence and creative power of our people, sustained for well over a century, has made BoehringerIngelheim a first-class, fast-growing pharmaceutical corporation. This is reflected at the Ben Venue Laboratories, Inc. We provide our employees demanding and challenging roles and the appropriate opportunities for development and career advancement at national and international levels, as well as performance-related total rewards.
10 articles with Ben Venue Laboratories
Ben Venue Laboratories Issues A Voluntary Nationwide Patient Level Recall Of Acetylcysteine Solution 10%, USP, Lot 2005479
Boehringer Ingelheim Corporation's Ben Venue Laboratories to Shut Down Operations Permanently; 1,100 Staffers Handed Pink Slips
Boehringer Mannheim Corporation's Ben Venue Laboratories to Trim Hundreds of Jobs, Will Cut Production Activity by Year's End
European Medicines Evaluation Agency Wants Two More Drugs Moved From Ben Venue Laboratories Due to Ongoing Manufacturing Practice Concerns
Sanofi (France)'s Genzyme Corporation Recalls 9,380 Vials of Fludara Leukemia Drug Made at Ben Venue Laboratories Plant
Vion Pharmaceuticals Enters Into Manufacturing Agreement For Cloretazine(R) (VNP40101M) With Ben Venue Laboratories